Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial.

Saved in:
Bibliographic Details
Title: Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial.
Authors: Keystone EC (AUTHOR), Kavanaugh AF (AUTHOR), Sharp JT (AUTHOR), Tannenbaum H (AUTHOR), Hua Y (AUTHOR), Teoh LS (AUTHOR), Fischkoff SA (AUTHOR), Chartash EK (AUTHOR)
Source: Arthritis & Rheumatism. May2004, Vol. 50 Issue 5, p1400-1411. 12p.
Database: Academic Search Ultimate
Description
ISSN:00043591
DOI:10.1002/art.20217